X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (96) 96
Publication (30) 30
Book / eBook (5) 5
Dissertation (2) 2
Book Review (1) 1
Conference Proceeding (1) 1
Newspaper Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (44) 44
humans (43) 43
infectious diseases (35) 35
female (34) 34
immunology (31) 31
hiv (29) 29
male (25) 25
hiv infections - drug therapy (24) 24
article (23) 23
infant (23) 23
uganda (23) 23
children (22) 22
malaria (20) 20
child (19) 19
human immunodeficiency virus--hiv (19) 19
pregnancy (19) 19
child, preschool (18) 18
pediatrics (17) 17
aids/hiv (16) 16
antiretroviral therapy (16) 16
adult (15) 15
viral load (15) 15
uganda - epidemiology (14) 14
drug therapy (13) 13
hiv infections - virology (13) 13
prevention (13) 13
anti-hiv agents - therapeutic use (12) 12
antiretroviral drugs (12) 12
infant, newborn (12) 12
treatment outcome (12) 12
virology (12) 12
africa (11) 11
research (11) 11
health aspects (10) 10
aids (9) 9
cd4 lymphocyte count (9) 9
prevalence (9) 9
risk factors (9) 9
incidence (8) 8
microbiology (8) 8
young adult (8) 8
abridged index medicus (7) 7
adolescent (7) 7
age (7) 7
antiretroviral therapy, highly active (7) 7
care and treatment (7) 7
cohort studies (7) 7
dosage and administration (7) 7
hiv infection in children (7) 7
hiv infections - complications (7) 7
hiv infections - immunology (7) 7
infection (7) 7
lopinavir - therapeutic use (7) 7
mortality (7) 7
parasitic diseases (7) 7
rural population (7) 7
therapy (7) 7
analysis (6) 6
antimalarials - therapeutic use (6) 6
children & youth (6) 6
efavirenz (6) 6
hiv infections - diagnosis (6) 6
hiv infections - epidemiology (6) 6
infants (6) 6
pregnancy complications, infectious - drug therapy (6) 6
protease inhibitors (6) 6
ritonavir - therapeutic use (6) 6
rna (6) 6
tropical medicine (6) 6
acquired immune deficiency syndrome--aids (5) 5
adults (5) 5
anti-retroviral agents - therapeutic use (5) 5
breast feeding (5) 5
complications and side effects (5) 5
drug therapy, combination (5) 5
hiv infection (5) 5
infections (5) 5
lopinavir/ritonavir (5) 5
malaria - drug therapy (5) 5
malaria - prevention & control (5) 5
perinatal transmission (5) 5
pharmacokinetics (5) 5
reverse transcriptase inhibitors - therapeutic use (5) 5
rna, viral - blood (5) 5
studies (5) 5
transmission (5) 5
vector-borne diseases (5) 5
anemia (4) 4
artemisinins - therapeutic use (4) 4
benzoxazines - administration & dosage (4) 4
cd8-positive t-lymphocytes - immunology (4) 4
comparative analysis (4) 4
disease transmission (4) 4
drugs (4) 4
follow-up studies (4) 4
gestational age (4) 4
hiv-1 - genetics (4) 4
hiv/aids (4) 4
immunodeficiency (4) 4
lopinavir (4) 4
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 11/2012, Volume 367, Issue 22, pp. 2110 - 2118
In HIV-infected Ugandan children, lopinavir–ritonavir–based ART was associated with a decreased incidence of malaria, as compared with ART based on an NNRTI,... 
TYPE-1 PROTEASE INHIBITORS | MEDICINE, GENERAL & INTERNAL | IN-VITRO | THERAPY | PLASMODIUM-FALCIPARUM | ARTEMETHER-LUMEFANTRINE | DRUGS | ANTIMALARIAL ACTIVITY | EXPOSURE | Artemisinins - pharmacokinetics | Humans | Fluorenes - therapeutic use | Child, Preschool | Infant | Male | Secondary Prevention | Incidence | Ethanolamines - pharmacokinetics | Drug Interactions | Malaria - epidemiology | Ritonavir - therapeutic use | Female | Reverse Transcriptase Inhibitors - therapeutic use | Drug Therapy, Combination | Fluorenes - pharmacokinetics | Anti-Retroviral Agents - therapeutic use | Antimalarials - pharmacokinetics | Kaplan-Meier Estimate | Antimalarials - therapeutic use | HIV Protease Inhibitors - therapeutic use | Malaria - prevention & control | Artemisinins - therapeutic use | Ethanolamines - therapeutic use | HIV Infections - drug therapy | Lopinavir - therapeutic use | Uganda | Malaria - drug therapy | Drug Combinations | Malaria | Patient outcomes | HIV infection in children | Research | Risk factors | Prevention | Complications and side effects | Highly active antiretroviral therapy | Reverse transcriptase inhibitors | Dosage and administration | Comparative analysis | Drug therapy | Health aspects | Antiretroviral drugs | Alanine | Ritonavir | Lopinavir | Insecticides | Proteinase inhibitors | Pruritus | Antiretroviral therapy | Antiretroviral agents | Human immunodeficiency virus--HIV | Alanine transaminase | Artemether | Children
Journal Article
Journal Article
PEDIATRIC RESEARCH, ISSN 0031-3998, 03/2018, Volume 83, Issue 3, pp. 747 - 747
This corrects the article DOI: 10.1038/pr.2014.47. 
PEDIATRICS | Neonatal care | Mothers | Infections
Journal Article
Cancer, ISSN 0008-543X, 11/2018, Volume 124, Issue 22, pp. 4332 - 4341
Journal Article
Journal Article
Malaria Journal, ISSN 1475-2875, 2010, Volume 9, Issue 1, pp. 177 - 177
Background: Daily trimethoprim-sulfamethoxazole (TS) protects against malaria, but efficacy may be diminished as anti-folate resistance increases. This study... 
FALCIPARUM DIHYDROFOLATE-REDUCTASE | PLASMODIUM-FALCIPARUM | THERAPEUTIC-EFFICACY | DIHYDROPTEROATE-SYNTHETASE GENES | INSECTICIDE-TREATED BEDNETS | SULFADOXINE-PYRIMETHAMINE RESISTANCE | ARTESUNATE PLUS AMODIAQUINE | POLYMERASE CHAIN-REACTION | UNCOMPLICATED MALARIA | HIV-1-INFECTED ADULTS | PARASITOLOGY | TROPICAL MEDICINE | Malaria, Falciparum - prevention & control | Prevalence | Follow-Up Studies | Dihydropteroate Synthase - genetics | HIV Infections - epidemiology | Humans | Child, Preschool | Uganda - epidemiology | Infant | Male | Plasmodium falciparum - drug effects | Case-Control Studies | Incidence | Insecticide-Treated Bednets | Plasmodium falciparum - genetics | Malaria, Falciparum - epidemiology | Polymerase Chain Reaction | Female | Child | Risk Factors | Treatment Outcome | Antimalarials - therapeutic use | Trimethoprim, Sulfamethoxazole Drug Combination - therapeutic use | Malaria, Falciparum - complications | Mutation - genetics | Polymorphism, Genetic | Tetrahydrofolate Dehydrogenase - metabolism | Drug Resistance - genetics | Malaria, Falciparum - parasitology | Mutation - drug effects | HIV Infections - complications | Dihydropteroate Synthase - metabolism | Folic Acid Antagonists - pharmacology | Drug Combinations | Cohort Studies | Tetrahydrofolate Dehydrogenase - genetics | Complications and side effects | Malaria | Demographic aspects | Co-trimoxazole | HIV infection in children | Dosage and administration | Research | Risk factors | Vector-borne diseases | Antiretroviral drugs | Mutations | Protocols | Human diseases | Bacterial infections | Genes | Prophylaxis | Cohorts | Health risks | Insecticides | Parasites | Drug resistance | Risks | Daily | Samples | Human immunodeficiency virus--HIV | Mutation | Children | Public health | Polymorphism
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 07/2019, Volume 381, Issue 3, pp. 219 - 229
Journal Article
Journal Article